Skip to content

NATESSENCE

Active Public limited companyfounded 1993active for 33 yearsRue de l'Avedelle 164, 7190 EcaussinnesKBO/BCE: BE 0449.788.802 subsidiary of #4 company by equity in Ecaussinnes, Wholesale and retail trade sector

Lifetime

21 annual accounts with figures on one time axis, 29 filings since 1994
peak of €502,043 in 2018
€164,345▼ 4.4%
lowest -€9,786 in 2025
-€9,786▼ €28,548
peak of €829,755 in 2023
€648,730▼ 1.5%
€752,105▲ 4.9%
peak of 2.3 FTE in 2021
0.9 FTE▲ 12.5%
Board4 names since 2018
1 director
Owners2 names in the annual accounts
  
Documentsfilings and deeds
02-07-202629 days before the deadline
2025abbreviated format
Loss of €9,786Staff from 0.8 FTE to 0.9 FTECash from €118,408 to €182,776

Key points

from the 2025 annual accounts

Staff

1 employees on 31-12-2025
01202134202300202411112025

In 2025, 11 employees joined and 11 left.

Filings

29 annual accounts since 1994
AprilJune31 JulyOctober200020102020

Seven of the last ten came late. The 2021 accounts came in latest, 89 days after the end of the period.

Position in the sector

-€9,786

Lower net result than 81% of companies in retail trade. Sector median €38,025 · 13,256 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 12,344 companies had the same profile as NATESSENCE has now. Each dot stands for 31 companies, two years later.

90.1%
were still trading
8.7%
stopped another way
0.7%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a small loss

Another 0.5% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,912 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 12,344 companies, not a prediction for NATESSENCE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director,
  • 100%score equity €292,691 (2025) · annual accounts 2024 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0449788802
1 director appointed, 2 resignations and resign · appointed as director · holds all the shares · General meeting of 22-12-2023 · Gazette deed
(director) and (director) reappointed Director discharge: · Director discharge: · Registered office clause: 7190 Ecaussinnes rue de l’Avedelle 164 · General meeting of 12-10-2023 · Gazette deed
resigns as director appointed as director · General meeting of 13-08-2020 · Gazette deed
All 42 events

Comparable companies

same main activity, similar in size and age
Company
NATESSENCE Ecaussinnes €1.4m €164,345 45.3% 0.9
APOTHEEK OBUS - DE GALAN Aalst €1.6m €151,303 47.9% 1
APOTEEK RIGAUX Merelbeke-Melle €1.2m €152,976 25.7% 1.1
APOTHEEK DE WILDE ZEE Antwerp €1.5m €130,936 3.6% 0.9
Apotheek Goddeeris Genk €1.4m €191,095 83.4% 1
Apotheek Verbanck Westerlo €1.4m €130,279 85.3% 1.1
PHARMACIE SCHOUTETEN Comines-Warneton €1.2m €171,634 55.3% 0.8

These companies have the same main activity as NATESSENCE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.2m and €1.6m, founded between 1985 and 2004.

Official details

Source: KBO
Status
Active since 29-03-1993Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.062.380.4457190 Ecaussinnes, since 08-06-1993
Financial year end
31 December
Peppol
Reachable since 12-09-2025
Company details

Annual accounts 2025

≈ €770,000estimated
€1.4m▲ 1.6%
Employeeson 31-12-2025
1=
Filing
Filed on 02-07-2026, 29 days before the end of the filing period
Financials

Insights on NATESSENCE

NATESSENCE files the abbreviated format. That format states no turnover. The gross margin rose from €121,542 in 2005 to €164,345 in 2025.

The balance sheet grew most from 2016 to 2018 through fixed assets, financed with long-term debt.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NATESSENCE

What is the company number of NATESSENCE?
The company number of NATESSENCE is 0449.788.802. The VAT number is the same number with BE in front: BE 0449.788.802.
Where is NATESSENCE based?
The registered office is at Rue de l'Avedelle 164, 7190 Ecaussinnes.Company details
What does NATESSENCE do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of NATESSENCE?
NATESSENCE is a public limited company (NV).
When was NATESSENCE founded?
NATESSENCE was founded on 29-03-1993.
Is NATESSENCE still active?
Yes, NATESSENCE is an active enterprise in the KBO register.
How many employees does NATESSENCE have?
NATESSENCE had an average of 0.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does NATESSENCE fall under?
In its 2025 annual accounts, NATESSENCE states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of NATESSENCE?
The turnover in financial year 2025 is ≈ €770,000. This figure is estimated from the gross margin of €164,345 and 43 comparable companies (NACE 477). It probably lies between €510,000 and €1.6m.
Is NATESSENCE profitable?
In financial year 2025, NATESSENCE made a loss of €9,786.
Where can I find the annual accounts of NATESSENCE?
NATESSENCE filed 29 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NATESSENCE due?
NATESSENCE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.